These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15159377

  • 41. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
    Mowry SE, Strocker AM, Chan J, Takehana C, Kalantar N, Bhuta S, Shapiro NL.
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
    [Abstract] [Full Text] [Related]

  • 42. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.
    Khanna R, Bell S, Sherritt M, Galbraith A, Burrows SR, Rafter L, Clarke B, Slaughter R, Falk MC, Douglass J, Williams T, Elliott SL, Moss DJ.
    Proc Natl Acad Sci U S A; 1999 Aug 31; 96(18):10391-6. PubMed ID: 10468618
    [Abstract] [Full Text] [Related]

  • 43. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
    Hoegh-Petersen M, Goodyear D, Geddes MN, Liu S, Ugarte-Torres A, Liu Y, Walker JT, Fonseca K, Daly A, Duggan P, Stewart D, Russell JA, Storek J.
    Bone Marrow Transplant; 2011 Aug 31; 46(8):1104-12. PubMed ID: 21057556
    [Abstract] [Full Text] [Related]

  • 44. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
    Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S.
    Transpl Infect Dis; 2006 Jun 31; 8(2):108-12. PubMed ID: 16734634
    [Abstract] [Full Text] [Related]

  • 45. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
    Rosselet A, Vu DH, Meylan P, Chaubert AS, Schapira M, Pascual M, Aubert V, Tissot JD, Duchosal MA.
    Clin Transplant; 2009 Jun 31; 23(1):74-82. PubMed ID: 19200218
    [Abstract] [Full Text] [Related]

  • 46. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar 31; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 47. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug 31; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 48. Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis.
    Saueressig MG, Boussaud V, Amrein C, Guillemain R, Souilamas J, Souilamas R.
    Clin Transplant; 2011 Aug 31; 25(4):E430-6. PubMed ID: 21518001
    [Abstract] [Full Text] [Related]

  • 49. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
    Liver Transpl; 2000 Jan 31; 6(1):62-6. PubMed ID: 10648579
    [Abstract] [Full Text] [Related]

  • 50. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 51. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E, Cornelissen JJ.
    Curr Opin Hematol; 2008 Nov 27; 15(6):576-85. PubMed ID: 18832928
    [Abstract] [Full Text] [Related]

  • 52. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
    Mautner J, Bornkamm GW.
    Eur J Cell Biol; 2012 Jan 27; 91(1):31-5. PubMed ID: 21458882
    [Abstract] [Full Text] [Related]

  • 53. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.
    Fukushima D, Sato K, Kawagishi N, Ohuchi N, Satomi S.
    Transplantation; 2015 Jan 27; 99(1):114-9. PubMed ID: 24846306
    [Abstract] [Full Text] [Related]

  • 54. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
    Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC.
    Pediatr Transplant; 2008 Nov 27; 12(7):778-84. PubMed ID: 18331541
    [Abstract] [Full Text] [Related]

  • 55. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J, Danielian S, Ibañez J, Turconi A, Cuarterolo M, Zelazko M, Niesters Hubert GM.
    J Clin Virol; 2004 Sep 27; 31(1):58-65. PubMed ID: 15288615
    [Abstract] [Full Text] [Related]

  • 56. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 57. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec 15; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 58. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.
    Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, Khanna R, Moss DJ.
    Transplantation; 2003 May 15; 75(9):1556-60. PubMed ID: 12792514
    [Abstract] [Full Text] [Related]

  • 59. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 60. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr 15; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.